Ledger.Open graph →
SEC Form D · Amendment · filed August 17, 2018

Prelude Therapeutics Inc

Offering
$30.0M
Sold
$30.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Wilmington, DE
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Paul Friedman · New York, NYDirectorKrishna Vaddi · Chadds Ford, PAExec · DirectorKrishna Vaddi · Chadds Ford, PAExec · DirectorPaul Friedman · San Francisco, CADirectorJuan Luengo · Newark, DEExecKelvin Neu · San Francisco, CADirectorDavid Bonita · Montreal, Quebec, CanadaDirectorJuan Luengo · Newark, DEExecKelvin Neu · Newark, DEDirectorDavid Bonita · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗